Sakai H - Search Results

1

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.

Niho S, Kunitoh H, Nokihara H, Horai T, Ichinose Y, Hida T, Yamamoto N, Kawahara M, Shinkai T, Nakagawa K, Matsui K, Negoro S, Yokoyama A, Kudoh S, Kiura K, Mori K, Okamoto H, Sakai H, Takeda K, Yokota S, Saijo N, Fukuoka M; JO19907 Study Group. Niho S, et al. Among authors: sakai h. Lung Cancer. 2012 Jun;76(3):362-7. doi: 10.1016/j.lungcan.2011.12.005. Epub 2012 Jan 14. Lung Cancer. 2012. PMID: 22244743 Free article. Clinical Trial.

2

Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer.

Sakai H, Yoneda S, Kobayashi K, Komagata H, Kosaihira S, Kazumoto T, Saito Y. Sakai H, et al. Lung Cancer. 2004 Feb;43(2):195-201. doi: 10.1016/j.lungcan.2003.08.021. Lung Cancer. 2004. PMID: 14739040 Clinical Trial.

3

S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.

Ichinose Y, Yoshimori K, Sakai H, Nakai Y, Sugiura T, Kawahara M, Niitani H. Ichinose Y, et al. Among authors: sakai h. Clin Cancer Res. 2004 Dec 1;10(23):7860-4. doi: 10.1158/1078-0432.CCR-04-1200. Clin Cancer Res. 2004. PMID: 15585618 Clinical Trial.

4

Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study.

Morishima Y, Ogura M, Yoneda S, Sakai H, Tobinai K, Nishiwaki Y, Minami H, Hotta T, Ezaki K, Ohe Y, Yokoyama A, Tsuboi M, Mori K, Watanabe K, Ohashi Y, Hirashima K, Saijo N; Japan Erythropoietin Study Group. Morishima Y, et al. Among authors: sakai h. Jpn J Clin Oncol. 2006 Oct;36(10):655-61. doi: 10.1093/jjco/hyl097. Epub 2006 Sep 20. Jpn J Clin Oncol. 2006. PMID: 16987908 Clinical Trial.

5

Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer.

Isobe K, Kobayashi K, Kosaihira S, Kurimoto F, Sakai H, Uchida Y, Nagai Y, Yamaguchi T, Miyanaga A, Ando M, Mori G, Hino M, Gemma A. Isobe K, et al. Among authors: sakai h. Lung Cancer. 2009 Dec;66(3):350-4. doi: 10.1016/j.lungcan.2009.03.003. Epub 2009 Apr 1. Lung Cancer. 2009. PMID: 19342118 Clinical Trial.

6

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy.

Maemondo M, Masuda N, Sekine I, Kubota K, Segawa Y, Shibuya M, Imamura F, Katakami N, Hida T, Takeo S; PALO Japanese Cooperative Study Group. Maemondo M, et al. Ann Oncol. 2009 Nov;20(11):1860-6. doi: 10.1093/annonc/mdp195. Epub 2009 Jun 26. Ann Oncol. 2009. PMID: 19561037 Free article. Clinical Trial.

7

A multi-institution phase I/II trial of triweekly regimen with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.

Kubota K, Sakai H, Yamamoto N, Kunitoh H, Nakagawa K, Takeda K, Ichinose Y, Saijo N, Ariyoshi Y, Fukuoka M. Kubota K, et al. Among authors: sakai h. J Thorac Oncol. 2010 May;5(5):702-6. doi: 10.1097/JTO.0b013e3181ce3e22. J Thorac Oncol. 2010. PMID: 20150827 Free article. Clinical Trial.

8

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nukiwa T; North-East Japan Study Group. Maemondo M, et al. N Engl J Med. 2010 Jun 24;362(25):2380-8. doi: 10.1056/NEJMoa0909530. N Engl J Med. 2010. PMID: 20573926 Free article. Clinical Trial.

9

Pooled analysis of S-1 trials in non-small cell lung cancer according to histological type.

Yamamoto N, Yamanaka T, Ichinose Y, Kubota K, Sakai H, Gemma A, Saijo N, Fukuoka M, Niitani H. Yamamoto N, et al. Among authors: sakai h. Anticancer Res. 2010 Jul;30(7):2985-90. Anticancer Res. 2010. PMID: 20683043 Clinical Trial.

10

Phase I study of topotecan and cisplatin in patients with small cell lung cancer.

Ichinose Y, Seto T, Nishiwaki Y, Kiura K, Sakai H, Yokoyama A, Segawa Y, Ando M, Watanabe K. Ichinose Y, et al. Among authors: sakai h. Jpn J Clin Oncol. 2011 Feb;41(2):197-203. doi: 10.1093/jjco/hyq177. Epub 2010 Oct 11. Jpn J Clin Oncol. 2011. PMID: 20937601 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,690 results

Search Page

Filters